Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Additionally we are shipping MMP16 Kits (14) and MMP16 Proteins (9) and many more products for this protein.
Showing 10 out of 108 products:
Human Polyclonal MMP16 Primary Antibody for IHC (p), WB - ABIN390140
Matsumoto, Katoh, Saito, Watanabe, Masuho: Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. in Biochimica et biophysica acta 1998
Show all 3 references for ABIN390140
Chicken Polyclonal MMP16 Primary Antibody for WB - ABIN2782697
Iida, Wilhelmson, Ng, Lee, Morrison, Tam, Overall, McCarthy: Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). in The Biochemical journal 2007
Neuronal knockdown of MT3-MMP resulted in the accumulation of NgR1 (show NEUROG1 Antibodies) at the cell surface and reduced the accumulation of the NgR1 (show NEUROG1 Antibodies) cleavage fragment in medium conditioned by cortical neurons
Study demonstrates that MT3-MMP, is expressed in mesenchymal tissues of the skeleton and in peri (show POSTN Antibodies)-skeletal soft connective tissue; and MT3-MMP-deficient mice display growth inhibition tied to a decreased viability of mesenchymal cells in skeletal tissues.
the results support a role for MMP16 in promoting invasive properties of the meningioma tumours
These results demonstrate that the MT3-MMP promoter is frequently hypermethylated in colorectal cancer and that downregulation of MT3-MMP may be important for cell migration in colorectal cancer.
MMP16 is a putative indicator of adverse melanoma prognosis.
Expression of MMP-16 in HTB9 and T24 cells increases following transforming growth factorbeta1 treatment.
E2F1 (show E2F1 Antibodies) acts as a transcriptional activator for MMPs and directly enhances MMP transcription by binding to E2F1 (show E2F1 Antibodies) binding sequences in the promoter, or indirectly activates MMPs (MMP-9 (show MMP9 Antibodies) and MMP-16)through enhanced Sp1 (show PSG1 Antibodies) and NF-kappa B (show NFKB1 Antibodies)
Matrix metalloproteinase 16 (MMP16) was a downstream target of miR (show MLXIP Antibodies)-146b-5p.
The overexpression of miR (show MLXIP Antibodies)-146b-5p in glioblastoma cell lines led to MMP16 mRNA silencing, MMP2 (show MMP2 Antibodies) inactivation, and the inhibition of tumour cell migration and invasion.
Data show that MMP16 is regulated by miR (show MLXIP Antibodies)-146a in spontaneously differentiated Caco-2 cells.
MT3-MMP is a matrix-dependent modifier of the invasive tumor cell functions during melanoma progression
Results report the structure of the catalytic domain (cd) of the membrane-type matrix metalloproteinase MT3-MMP/MMP-16 in complex with the hydroxamic acid inhibitor batimastat.
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The encoded protein activates MMP2 by cleavage. This gene was once referred to as MT-MMP2, but was renamed as MT-MMP3 or MMP16.
, MT-MMP 3
, Membrane type 3-MMP
, matrix metalloproteinase 16
, matrix metalloproteinase-16
, membrane-type matrix metalloproteinase 3
, membrane-type-3 matrix metalloproteinase
, Putative transmembrane protein C8orf57
, matrix metalloproteinase 16 (membrane-inserted)
, membrane type-matrix metalloproteinase